| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.009 |